These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31932681)

  • 21. Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential.
    Giner-Calabuig M; De Leon S; Wang J; Fehlmann TD; Ukaegbu C; Gibson J; Alustiza-Fernandez M; Pico MD; Alenda C; Herraiz M; Carrillo-Palau M; Salces I; Reyes J; Ortega SP; Obrador-Hevia A; Cecchini M; Syngal S; Stoffel E; Ellis NA; Sweasy J; Jover R; Llor X; Xicola RM
    Br J Cancer; 2022 Jun; 126(11):1595-1603. PubMed ID: 35197584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted sequencing of genes associated with the mismatch repair pathway in patients with endometrial cancer.
    Singh AK; Talseth-Palmer B; McPhillips M; Lavik LAS; Xavier A; Drabløs F; Sjursen W
    PLoS One; 2020; 15(7):e0235613. PubMed ID: 32634176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer.
    Nguyen-Dumont T; Steen JA; Winship I; Park DJ; Pope BJ; Hammet F; Mahmoodi M; Tsimiklis H; Theys D; Clendenning M; Giles GG; Hopper JL; Southey MC
    Fam Cancer; 2020 Jul; 19(3):197-202. PubMed ID: 32060697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Comprehensive Study of Heterogeneous Mismatch Repair Expression in Solid Tumors Reveals Different Immunohistochemical Patterns and Distinct Genetic Mechanisms.
    Wang J; Zhang Z; Cai Y; Lu J; Zhang H; Pang J; Wu H; Liang Z
    Am J Surg Pathol; 2024 Apr; 48(4):417-425. PubMed ID: 37997470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
    Møller P; Seppälä T; Bernstein I; Holinski-Feder E; Sala P; Evans DG; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Frayling IM; Plazzer JP; Pylvanainen K; Sampson JR; Capella G; Mecklin JP; Möslein G;
    Gut; 2017 Mar; 66(3):464-472. PubMed ID: 26657901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights into Lynch Syndrome: A Narrative Review.
    Ene CV; Bulai CTLA; Geavlete P; Popescu RI; Vacaroiu IA; Georgescu DE; Isaconi IV; Munteanu MDLA; Ene CD; Militaru A; Geavlete B; Multescu R
    Chirurgia (Bucur); 2023 Dec; 118(6):584-595. PubMed ID: 38228591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and characteristics of patients with upper urinary tract urothelial carcinoma having potential Lynch syndrome identified by immunohistochemical universal screening and Amsterdam criteria II.
    Tanabe K; Nakanishi Y; Okubo N; Matsumoto S; Umino Y; Kataoka M; Yajima S; Yoshida T; Miyazaki S; Kuwata T; Ishii G; Watanabe R; Masuda H
    BMC Cancer; 2023 Oct; 23(1):940. PubMed ID: 37798659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of immediate germline sequencing and multi-step screening for Lynch syndrome detection in high-risk endometrial and colorectal cancer patients.
    Chao AS; Chao A; Lai CH; Lin CY; Yang LY; Chang SC; Wu RC
    J Gynecol Oncol; 2024 Jan; 35(1):e5. PubMed ID: 37743058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lynch syndrome-associated upper tract urothelial carcinoma frequently occurs in patients older than 60 years: an opportunity to revisit urology clinical guidelines.
    Pivovarcikova K; Pitra T; Alaghehbandan R; Buchova K; Steiner P; Hajkova V; Ptakova N; Subrt I; Skopal J; Svajdler P; Farcas M; Slisarenko M; Michalova K; Strakova Peterikova A; Hora M; Michal M; Daum O; Svajdler M; Hes O
    Virchows Arch; 2023 Oct; 483(4):517-526. PubMed ID: 37612527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.
    Walsh MD; Buchanan DD; Cummings MC; Pearson SA; Arnold ST; Clendenning M; Walters R; McKeone DM; Spurdle AB; Hopper JL; Jenkins MA; Phillips KD; Suthers GK; George J; Goldblatt J; Muir A; Tucker K; Pelzer E; Gattas MR; Woodall S; Parry S; Macrae FA; Haile RW; Baron JA; Potter JD; Le Marchand L; Bapat B; Thibodeau SN; Lindor NM; McGuckin MA; Young JP
    Clin Cancer Res; 2010 Apr; 16(7):2214-24. PubMed ID: 20215533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Context-dependent environmental associations with endometrial cancer histotype and genotype.
    Nakad Borrego S; Kurnit K; Turner LJ; Broaddus RR
    Int J Gynecol Cancer; 2023 Aug; 33(8):1215-1221. PubMed ID: 37380216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do the risks of Lynch syndrome-related cancers depend on the parent of origin of the mutation?
    Gemechu SD; van Vliet CM; Win AK; Figueiredo JC; Le Marchand L; Gallinger S; Newcomb PA; Hopper JL; Lindor NM; Jenkins MA; Dowty JG
    Fam Cancer; 2020 Jul; 19(3):215-222. PubMed ID: 32107660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional loss of MSH2 and MSH6 expression in sporadic deficient mismatch repair colorectal cancer due to MLH1 promoter hypermethylation.
    Westwood A; Glover A; Hutchins G; Young C; Brockmoeller S; Robinson R; Worrilow L; Wallace D; Rankeillor K; Adlard J; Quirke P; West N
    J Clin Pathol; 2019 Jun; 72(6):443-447. PubMed ID: 30723092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
    Kim H; Lim KY; Park JW; Kang J; Won JK; Lee K; Shim Y; Park CK; Kim SK; Choi SH; Kim TM; Yun H; Park SH
    Lab Invest; 2022 Feb; 102(2):160-171. PubMed ID: 34848827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glioma arising in the setting of mismatch repair deficiency-rare or are we missing it?
    Goyal A; Rao S; Rishi KS; Ramaswamy V; Sadashiva N; Santosh V
    Childs Nerv Syst; 2024 Jan; 40(1):233-237. PubMed ID: 37733272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing landscape of Lynch syndrome due to PMS2 mutations.
    Blount J; Prakash A
    Clin Genet; 2018 Jul; 94(1):61-69. PubMed ID: 29286535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas.
    Pino MS; Mino-Kenudson M; Wildemore BM; Ganguly A; Batten J; Sperduti I; Iafrate AJ; Chung DC
    J Mol Diagn; 2009 May; 11(3):238-47. PubMed ID: 19324997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value.
    Berg HF; Engerud H; Myrvold M; Lien HE; Hjelmeland ME; Halle MK; Woie K; Hoivik EA; Haldorsen IS; Vintermyr O; Trovik J; Krakstad C
    Br J Cancer; 2023 Feb; 128(4):647-655. PubMed ID: 36482191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lynch syndrome: case report and review of the literature].
    Bouguenouch L; Samri I; Belhassan K; Sayel H; Abbassi M; Bennis S; Benajah DA; Ibrahimi A; Amarti A; Ouldim K
    Pan Afr Med J; 2016; 24():142. PubMed ID: 27642480
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.